The Lancet Diabetes & Endocrinology: Economic growth linked to reduction in stunting and thinness, but rise in overweight and obesity in Chinese children and adolescents

March 19, 2019

The first study to evaluate the effect of economic growth on malnutrition in all its forms has found that, while stunting and thinness have ameliorated in recent years, a four-fold increase in overweight and obesity among children and adolescents occurred in China between 1995 and 2014, with around one in five children and adolescents now either overweight or obese.

The research, published in The Lancet Diabetes & Endocrinology journal, shows that although economic growth might contribute to the reductions in stunting and thinness, its double-edged sword effect on the marked increase in overweight and obesity highlights a need to proactively adopt strategies to ensure dietary quality and diversity as well as maintenance of physical activity in a context of rapid economic growth and urbanisation.

China's economy boomed from 2000 to 2014, and it is now the second largest in the world. Such growth has many societal impacts and China has made great progress in reducing poverty and hunger, but has also seen an increase in non-communicable diseases in adults.

Previous research has shown that economic development improves child health and nutrition, though this is by no means universal, and better nutrition can go hand in hand with increases in obesity. This study aimed to investigate whether urban-rural inequalities in nutritional status changed in China during the period surveyed and to assess the associations between shifts in three indicators -- stunting, thinness and overweight and obesity -- and nutritional status changes. Meanwhile, they used three indicators of socioeconomic development: per capita GDP, Engel coefficient - a measure of the proportion of income spent on food - and urbanisation data.

The team extracted data from the 1995, 2000, 2005, 2010 and 2014 cycles of the Chinese National Survey on students' Constitution and Health, so far, the largest nationally representative study of Chinese school-aged child and adolescent health status. They included 1,054,602 participants aged between 7 and 18 years, with complete records on age, sex, nationality, height and weight in the final analysis.

The survey observes increases in average height, weight, and BMI, and the prevalence of overweight and obesity, as well as average GDP per capita and urbanisation ratio from 1995 to 2014, while the prevalence of stunting and thinness and the Engel coefficient steadily declined.

Between 1995 and 2014, stunting prevalence in Chinese children and adolescents decreased from 8.1% to 2.4% and thinness prevalence declined from 7.5% to 4.1%. On average, overweight and obesity prevalence increased from 5.3% to 20.5%. During the period observed, provinces with higher GDP per capita led the transition with faster transition to reductions in thinness and stunting, and increases in obesity and overweight.

Urban children and adolescents had a lower prevalence of stunting and thinness than did those in rural areas, though there was narrowing difference between urban and rural populations over time. The urban-rural disparity reduced over time for average height, prevalence of stunting and prevalence of overweight and obesity.

Co-author Professor Jun Ma, Peking University in China, says: "Socioeconomic development has brought rapid changes in nutrition in Chinese children and adolescents and there are important improvements in stunting and thinness. We are concerned to see such a marked increase in overweight and obesity. This suggests a pressing need for policy responses that may include taxation of food and beverage with added sugars and fats, subsidies to promote dietary diversity, and strategies to promote physical activity and health education." [1]

The findings of the study vary from trends elsewhere in the world - such as in the UK, where the trend has now reversed and low socioeconomic status is linked with being overweight or obese. In the future, this could begin to be seen in China and in other low and middle income countries as they increase their socioeconomic status. The authors note that some areas in China with higher socioeconomic development such as Beijing and Shandong, are starting to show such a reversed pattern, with rural children affected by a dual burden of undernutrition and overnutrition.

The findings of this research suggest that there is a value in using multiple indicators to track social and economic developments, particularly in many lower and middle income countries where direct indicators of nutritional status are not available. Policies such as taxation of foods with high sugar and fat and financial subsidies for nutritional diversity along with health education could be important in groups and places where economic development is slower.

The authors note some limitations. Firstly, it only analysed Han Chinese children and adolescents so may not apply to other ethnic groups, and the survey took place in school attendees only. The authors calculated socioeconomic indicators at a provincial level rather than average individual- or household-level data.

While the study does not capture population mobility in China (which has been substantial over the 20 year period studied), the authors address this through stratification by urbanisation in the study years. In addition, movement is unlikely in the population observed due to the need for compulsory attendance at school and a law requiring people's registration to an area.

Writing in a linked Comment, Dr Lindsay M Jaacks of the Harvard TH Chan School of Public Health, USA, says: "These results do not necessarily call for less economic growth but for more equitable and sustainable economic growth. Implementation of policies that promote healthier patterns of behaviour and greater regulation of the food industry should be a priority for China and others striving to end all forms of malnutrition."
Peer-reviewed / Observational study / People


This study was funded by National Natural Science Foundation, The Research Special Fund for Public Welfare Industry of Health of the Ministry of Health of China, and China Scholarship Council. It was conducted by researchers from Peking University, University of New South Wales, Hunan Normal University, Monash University, The University of Melbourne, Murdoch Children's Research Institute, Royal Children's Hospital, Melbourne.

The labels have been added to this press release as part of a project run by the Academy of Medical Sciences seeking to improve the communication of evidence. For more information, please see: if you have any questions or feedback, please contact The Lancet press office

[1] Quote direct from author and cannot be found in the text of the Article..


The Lancet

Related Obesity Articles from Brightsurf:

11 years of data add to the evidence for using testosterone therapy to treat obesity, including as an alternative to obesity surgery
New research covering 11 years of data presented at this year's European and International Congress on Obesity (ECOICO 2020) show that, in obese men suffering from hypogonadism (low testosterone), treatment with testosterone injections lowers their weight and improves a wide range of other metabolic parameters.

Overlap between immunology of COVID-19 and obesity could explain the increased risk of death in people living with obesity, and also older patients
Data presented in a special COVID-19 session at the European and International Congress on Obesity (ECOICO 2020) suggests that there are overlaps between the immunological disturbances found in both COVID-19 disease and patients with obesity, which could explain the increased disease severity and mortality risk faced by obese patients, and also elderly patients, who are infected by the SARS-CoV-2 virus that causes COVID-19 disease.

New obesity guideline: Address root causes as foundation of obesity management
besity management should focus on outcomes that patients consider to be important, not weight loss alone, and include a holistic approach that addresses the root causes of obesity, according to a new clinical practice guideline published in CMAJ (Canadian Medical Association Journal)

Changing the debate around obesity
The UK's National Health Service (NHS) needs to do more to address the ingrained stigma and discrimination faced by people with obesity, says a leading health psychologist.

Study links longer exposure to obesity and earlier development of obesity to increased risk of type 2 diabetes
Cumulative exposure to obesity could be at least as important as actually being obese in terms of risk of developing type 2 diabetes (T2D), concludes new research published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]).

How much do obesity and addictions overlap?
A large analysis of personality studies has found that people with obesity behave somewhat like people with addictions to alcohol or drugs.

Should obesity be recognized as a disease?
With obesity now affecting almost a third (29%) of the population in England, and expected to rise to 35% by 2030, should we now recognize it as a disease?

Is obesity associated with risk of pediatric MS?
A single-center study of 453 children in Germany with multiple sclerosis (MS) investigated the association of obesity with pediatric MS risk and with the response of first-line therapy in children with MS.

Women with obesity prior to conception are more likely to have children with obesity
A systematic review and meta-analysis identified significantly increased odds of child obesity when mothers have obesity before conception, according to a study published June 11, 2019 in the open-access journal PLOS Medicine by Nicola Heslehurst of Newcastle University in the UK, and colleagues.

Obesity medicine association announces major updates to its adult obesity algorithm
The Obesity Medicine Association (OMA) announced the immediate availability of the 2019 OMA Adult Obesity Algorithm, with new information for clinicians including the relationship between Obesity and Cardiovascular Disease, Diabetes Mellitus, Dyslipidemia, and Cancer; information on investigational Anti-Obesity Pharmacotherapy; treatments for Lipodystrophy; and Pharmacokinetics and Obesity.

Read More: Obesity News and Obesity Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to